InvestorsHub Logo
Followers 87
Posts 32828
Boards Moderated 1
Alias Born 12/19/2004

Re: None

Monday, 08/28/2017 1:29:43 PM

Monday, August 28, 2017 1:29:43 PM

Post# of 37067
"PLAN OF OPERATION AND FUNDING

We have incurred losses for the past three fiscal years and had a net loss of $105,638 at June 30, 2017 and $103,928 at June 30, 2016. We had insufficient funds to deliver our backlog in the last half of 2016 through the present. Our revenues from product sales have been insufficient to cover our operating expenses. Our auditors have expressed substantial doubt that we can continue as a going concern. We have continued to push service contracts and control costs but the large overwhelming marketing budgets of our competitors in spite of our superior technology has diminished our ability to compete.

Our Board of Directors has decided to broaden our perspective and add additional business related or unrelated to the current security product market. Two of our directors are physicians and both have investigated the Erectile Dysfunction market. Our Board of Directors has decided to pursue the Erectile Dysfunction Medical market.

According to Pew Research, 10,000 Baby Boomers turn 65 every day, of which 49% are men. This ensures that we will have an expanding pool of prospective clients, and thus make possible the exponential growth of patients each year until 2030. We have announced on January 6th the acquisition of a company called Y.M. Advantage, Inc. This company is a private entity engaged in the acquisition, development and management of medical clinics specializing in boutique procedures such as treatment for erectile dysfunction, hair restoration and a variety of specialized men's health therapeutic procedures. The current US market estimates for erectile dysfunction therapies is upwards of $6 Billion.

The business strategy will be to establish multiple concierge, all-inclusive medical practices, providing a "one-stop shop" for most issues relating to male sexual dysfunction, including erectile dysfunction, testosterone replacement therapy, and premature ejaculation. By establishing or acquiring "men's clinics" in select geographic areas, View's business strategy is to capitalize on two irrefutable trends that are currently at play in the marketplace: an aging population and the rising prevalence of certain medical conditions cause erectile dysfunction such as diabetes, high blood pressure, smoking, obesity prostate issues etc.

We have decided to call the wholly owned sub of View Systems Medical Therapeutics. We operate one clinic so far and plan to open in multiple cities where the population density is in excess of 300,000.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.